Founded with a mission to revolutionize wound care, Preventogen develops FDA-cleared polymers designed to prevent infections and promote healing. Their core product is a liquid polymer that kills microbes on contact, forming a flexible, biodegradable barrier over wounds, surgical incisions, abrasions, and burns. This barrier protects against harmful elements like water, dirt, and germs while creating an optimal healing environment by lowering the pH and preventing oxygen from entering the wound.
Preventogen has garnered attention for its innovative approach to infection prevention, attracting notable investors and healthcare professionals. The company's FDA clearance is a significant milestone, validating the efficacy and safety of their product. Preventogen's impact is evident in clinical settings where their polymer has improved patient outcomes by reducing infection rates and enhancing the healing process. Through continuous innovation and commitment to patient care, Preventogen is poised to make a lasting impact on the healthcare industry.
